ClinicalTrials.Veeva

Menu

Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Lung Diseases, Interstitial
Lung Diseases, Obstructive
Lung Disease Chronic

Treatments

Other: 6-minute walk distance (6MWD) test on ambient air
Other: 6-minute walk distance test with supplemental oxygen (approximately 3l/min, nasal)

Study type

Interventional

Funder types

Other

Identifiers

NCT06385301
Lung_disease_6MWD_SOT

Details and patient eligibility

About

The investigators aim to study the effect of SOT in subjects with chronic lung disease in submaximal exercise.

Full description

Participants with lung disease who live in Switzerland will have 6-minute walk distance (6MWD) test with and without SOT at approximately 3l/min via nasal cannula according to a randomized cross-over design.

The trial aims to test that the 6MWD with SOT is non-inferior to a 6MWD in the same participant under ambient air.

Our effect size was estimated with a difference of less or equal to 35m compared under SOT compared to ambient air.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Minimum 18 years of age
  • Written informed consent
  • Patients with diagnosed chronic lung disease
  • Former desaturation under exercise defined as Spo2-decrease >3%- Page 3 of 4
  • Treated with a stable drug therapy (with no changes for at least 14 days prior to screening)

Exclusion criteria

  • Severe hypoxemia needing supplemental oxygen therapy defined as (partial pressure of Oxygen (PaO2) < 6.9 KiloPascal (kPa)
  • Pregnancy
  • Unability or contraindications to undergo the investigated intervention
  • Unability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Ambient air
Experimental group
Description:
Patient will perform tests at University Hospital Zurich on ambient air
Treatment:
Other: 6-minute walk distance (6MWD) test on ambient air
SOT via basal cannula
Active Comparator group
Description:
Supplemental Oxygen Therapy (SOT) will be provided via nasal cannula from a small oxygen concentrator while the patient performs tests at University Hospital Zurich.
Treatment:
Other: 6-minute walk distance test with supplemental oxygen (approximately 3l/min, nasal)

Trial contacts and locations

1

Loading...

Central trial contact

Silvia Ulrich, Prof. Dr.; Mona Lichtblau, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems